Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pamela J. Thompson is active.

Publication


Featured researches published by Pamela J. Thompson.


Drug and Alcohol Dependence | 2002

Using qualitative research to inform survey development on nicotine dependence among adolescents

Mark Nichter; Mimi Nichter; Pamela J. Thompson; Saul Shiffman; Anna-Barbara Moscicki

Researchers interested in measuring tobacco use and dependence among youth face several formidable challenges. These challenges include: most existing measures have been developed for adult samples and may not be suitable for adolescent respondents; surveys must be relevant to different youth subcultures and to both genders; questions must be developmentally appropriate and not perceived as judgmental or condescending; and the multidimensional nature of nicotine dependence in youth must be recognized and measured. This paper demonstrates how researchers can address these challenges by using qualitative techniques to obtain information on youth tobacco consumption, and then using this information to inform the development of quantitative instruments. A case study is presented where a measure of tobacco dependence originally developed for adults is adapted for use with adolescents. A seven-step formative research process is outlined, consisting of gathering information in open-ended interviews, conducting follow-up research, modification of questionnaire items and addition of new items based on the information gathered, constructing a reliable instrument that is readable and acceptable to youth, reducing the length of this instrument without significantly hurting reliability and validity, conducting additional follow-up research involving case studies, and examining cultural differences. Following a formative research process like this one will help tobacco researchers gain a better understanding of how nicotine dependence develops.


Journal of Clinical Microbiology | 2006

Comparison of Physician- and Self-Collected Genital Specimens for Detection of Human Papillomavirus in Men

Brenda Y. Hernandez; Marc T. Goodman; Lynne R. Wilkens; Pamela J. Thompson; Xuemei Zhu; W. Wong; Lily Ning

ABSTRACT There is currently no consensus regarding the most appropriate methods of sampling for the detection of genital human papillomavirus (HPV) in men. We employed a recently developed collection method involving abrasion and moistened swabbing of the genital skin surface for the detection of HPV in a cohort of 136 university-affiliated males in Hawaii. Genital specimens collected by physicians using this method were compared with self-collected specimens from the same individuals obtained 24 h later. Self-collected specimens yielded a greater proportion of sufficient specimens than physician-collected specimens. HPV detection was comparable in physician- and self-collected specimens; detection was highest in the penile shaft (51.2% and 51.5%, respectively, P = 0.96), followed by the scrotum (41.2% and 46.2%, P = 0.43), the glans/coronal sulcus (31.9% and 33.1%, P = 0.84), and the foreskin (33.3% and 28.6%, P = 0.74). Site-specific agreement in HPV detection between paired physician- and self-collected samples ranged from 67.2% (kappa = 0.34) for the penile shaft to 95.0% (kappa = 0.89) for the foreskin. There was a high degree of concordance in HPV genotypes in HPV-positive pairs. The most common type was HPV type 84, which comprised approximately 15% of the specimens. The emery paper-swab method offers an efficient sampling method for genital HPV DNA detection in men that could be used both within and outside of the clinical setting.


PLOS Genetics | 2010

Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "Hot-Spot"

Sharon E. Johnatty; Jonathan Beesley; Xiaoqing Chen; Stuart Macgregor; David L. Duffy; Amanda B. Spurdle; Anna deFazio; Natalie Gava; Penelope M. Webb; Australian Cancer Study; Mary Anne Rossing; Jennifer A. Doherty; Mt Goodman; Galina Lurie; Pamela J. Thompson; Lynne R. Wilkens; Roberta B. Ness; Kirsten B. Moysich; Jenny Chang-Claude; Shan Wang-Gohrke; Daniel W. Cramer; Kathryn L. Terry; Susan E. Hankinson; Shelley S. Tworoger; Montserrat Garcia-Closas; Hannah P. Yang; Jolanta Lissowska; Stephen J. Chanock; Paul Pharoah; Honglin Song

We hypothesized that variants in genes expressed as a consequence of interactions between ovarian cancer cells and the host micro-environment could contribute to cancer susceptibility. We therefore used a two-stage approach to evaluate common single nucleotide polymorphisms (SNPs) in 173 genes involved in stromal epithelial interactions in the Ovarian Cancer Association Consortium (OCAC). In the discovery stage, cases with epithelial ovarian cancer (nu200a=u200a675) and controls (nu200a=u200a1,162) were genotyped at 1,536 SNPs using an Illumina GoldenGate assay. Based on Positive Predictive Value estimates, three SNPs—PODXL rs1013368, ITGA6 rs13027811, and MMP3 rs522616—were selected for replication using TaqMan genotyping in up to 3,059 serous invasive cases and 8,905 controls from 16 OCAC case-control studies. An additional 18 SNPs with P per-allele<0.05 in the discovery stage were selected for replication in a subset of five OCAC studies (nu200a=u200a1,233 serous invasive cases; nu200a=u200a3,364 controls). The discovery stage associations in PODXL, ITGA6, and MMP3 were attenuated in the larger replication set (adj. P per-allele≥0.5). However genotypes at TERT rs7726159 were associated with ovarian cancer risk in the smaller, five-study replication study (P per-alleleu200a=u200a0.03). Combined analysis of the discovery and replication sets for this TERT SNP showed an increased risk of serous ovarian cancer among non-Hispanic whites [adj. ORper-allele 1.14 (1.04–1.24) pu200a=u200a0.003]. Our study adds to the growing evidence that, like the 8q24 locus, the telomerase reverse transcriptase locus at 5p15.33, is a general cancer susceptibility locus.


Cancer Research | 2009

Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

Joellen M. Schildkraut; Ellen L. Goode; Merlise A. Clyde; Edwin S. Iversen; Patricia G. Moorman; Andrew Berchuck; Jeffrey R. Marks; Jolanta Lissowska; Louise A. Brinton; Beata Peplonska; Julie M. Cunningham; Robert A. Vierkant; David N. Rider; Georgia Chenevix-Trench; Penelope M. Webb; Jonathan Beesley; Xiaoqing Chen; Catherine M. Phelan; Rebecca Sutphen; Thomas A. Sellers; Leigh Pearce; Anna H. Wu; David Van Den Berg; David V. Conti; Christopher K. Elund; Rebecca Anderson; Marc T. Goodman; Galina Lurie; Michael E. Carney; Pamela J. Thompson

The p53 protein is critical for multiple cellular functions including cell growth and DNA repair. We assessed whether polymorphisms in the region encoding TP53 were associated with risk of invasive ovarian cancer. The study population includes a total of 5,206 invasive ovarian cancer cases (2,829 of which were serous) and 8,790 controls from 13 case-control or nested case-control studies participating in the Ovarian Cancer Association Consortium (OCAC). Three of the studies performed independent discovery investigations involving genotyping of up to 23 single nucleotide polymorphisms (SNP) in the TP53 region. Significant findings from this discovery phase were followed up for replication in the other OCAC studies. Mixed effects logistic regression was used to generate posterior median per allele odds ratios (OR), 95% probability intervals (PI), and Bayes factors (BF) for genotype associations. Five SNPs showed significant associations with risk in one or more of the discovery investigations and were followed up by OCAC. Mixed effects analysis confirmed associations with serous invasive cancers for two correlated (r(2) = 0.62) SNPs: rs2287498 (median per allele OR, 1.30; 95% PI, 1.07-1.57) and rs12951053 (median per allele OR, 1.19; 95% PI, 1.01-1.38). Analyses of other histologic subtypes suggested similar associations with endometrioid but not with mucinous or clear cell cancers. This large study provides statistical evidence for a small increase in risk of ovarian cancer associated with common variants in the TP53 region.


Journal of Adolescent Health | 2003

Effects of pro- and anti-tobacco advertising on nonsmoking adolescents’ intentions to smoke

Diane M Straub; Nancy K. Hills; Pamela J. Thompson; Anna-Barbara Moscicki

PURPOSEnTo determine the effects of pro- and anti-tobacco advertising on nonsmoking adolescents intention to smoke in a single cohort.nnnMETHODSnAll ninth graders at seven public high schools were invited to participate in a study on adolescent tobacco use; 59.0% participated (n = 1229; active positive parental consent required). Adolescents who self-identified as never having smoked even a puff of a cigarette (n = 512) completed a self-administered questionnaire that included questions on intention to smoke in the near future and tobacco advertising. Independent variables used to predict intention included exposure to, recognition of, and receptivity and attitudes toward pro-tobacco and anti-tobacco advertising. Potential confounding variables included gender, race/ethnicity, smoking influences (adult household members, siblings, and friends), socioeconomic status, stress, and depression. Data analysis used logistic regression.nnnRESULTSnnnnDEMOGRAPHICSn50.5% female, average age 14.9 +/- 0.4 years old at baseline, and varied race. Those variables found to be significant predictors of intention to smoke included: (positive, or increased intention) recognition of brand of favorite advertisement, willingness to use or wear tobacco-branded products, stress, and having friends who smoke and (negative, or decreased intention) agreement with anti-tobacco advertising and having a live-in father who smokes.nnnCONCLUSIONSnAlthough anti-tobacco advertising has a protective effect, it was unable to counteract the effects of pro-tobacco advertising in the same cohort.


Cancer Epidemiology, Biomarkers & Prevention | 2010

ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.

Jennifer A. Doherty; Mary Anne Rossing; Kara L. Cushing-Haugen; Chu Chen; David Van Den Berg; Anna H. Wu; Malcolm C. Pike; Roberta B. Ness; Kirsten B. Moysich; Georgia Chenevix-Trench; Jonathan Beesley; Penelope M. Webb; Jenny Chang-Claude; Shan Wang-Gohrke; Marc T. Goodman; Galina Lurie; Pamela J. Thompson; Michael E. Carney; Estrid Høgdall; Susanne K. Kjaer; Claus Høgdall; Ellen L. Goode; Julie M. Cunningham; Brooke L. Fridley; Robert A. Vierkant; Andrew Berchuck; Patricia G. Moorman; Joellen M. Schildkraut; Rachel T. Palmieri; Daniel W. Cramer

We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls, respectively. A SNP 19 kb downstream of ESR1 (rs2295190, G-to-T change) was associated with invasive ovarian cancer risk, with a per-T-allele odds ratio (OR) of 1.24 [95% confidence interval (CI), 1.06-1.44, P = 0.006]. rs2295190 is a nonsynonymous coding SNP in a neighboring gene called spectrin repeat containing, nuclear envelope 1 (SYNE1), which is involved in nuclear organization and structural integrity, function of the Golgi apparatus, and cytokinesis. An isoform encoded by SYNE1 has been reported to be downregulated in ovarian and other cancers. rs2295190 was genotyped in an additional 12 studies through the Ovarian Cancer Association Consortium, with 5,279 invasive epithelial cases and 7,450 controls. The per-T-allele OR for this 12-study set was 1.09 (95% CI, 1.02-1.17; P = 0.017). Results for the serous subtype in the 15 combined studies were similar to those overall (n = 3,545; OR, 1.09; 95% CI, 1.01-1.18; P = 0.025), and our findings were strongest for the mucinous subtype (n = 447; OR, 1.32; 95% CI, 1.11-1.58; P = 0.002). No association was observed for the endometrioid subtype. In an additional analysis of 1,459 borderline ovarian cancer cases and 7,370 controls, rs2295190 was not associated with risk. These data provide suggestive evidence that the rs2295190 T allele, or another allele in linkage disequilibrium with it, may be associated with increased risk of invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev; 19(1); 244–50


The Journal of Infectious Diseases | 2010

Reduced Clearance of Penile Human Papillomavirus Infection in Uncircumcised Men

Brenda Y. Hernandez; Yurii B. Shvetsov; Marc T. Goodman; Lynne R. Wilkens; Pamela J. Thompson; Xuemei Zhu; Lily Ning

The relationship between circumcision and the acquisition and clearance of human papillomavirus (HPV) infection was examined in a cohort of 357 men followed up at 2-month intervals for an average of 431 days. There were no differences in HPV acquisition by circumcision status. Clearance of HPV infection, including infection with oncogenic types, was slower in the glans/coronal sulcus of the penis of uncircumcised men than circumcised men. The median duration of HPV infection of the glans/coronal sulcus was significantly longer in uncircumcised men (154 days) than circumcised men (91 days) (P=.04). Circumcision may protect against HPV-associated disease by enhancing the resolution of infection.


Cancer Causes & Control | 2013

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

Mette T. Faber; Susanne K. Kjaer; Christian Dehlendorff; Jenny Chang-Claude; Klaus Kaae Andersen; Estrid Høgdall; Penelope M. Webb; Susan Jordan; Mary Anne Rossing; Jennifer A. Doherty; Galina Lurie; Pamela J. Thompson; Michael E. Carney; Marc T. Goodman; Roberta B. Ness; Francesmary Modugno; Robert P. Edwards; Clareann H. Bunker; Ellen L. Goode; Brooke L. Fridley; Robert A. Vierkant; Melissa C. Larson; Joellen M. Schildkraut; Daniel W. Cramer; Kathryn L. Terry; Allison F. Vitonis; Elisa V. Bandera; Sara H. Olson; Melony King; Urmila Chandran

PurposeThe majority of previous studies have observed an increased risk of mucinous ovarian tumors associated with cigarette smoking, but the association with other histological types is unclear. In a large pooled analysis, we examined the risk of epithelial ovarian cancer associated with multiple measures of cigarette smoking with a focus on characterizing risks according to tumor behavior and histology.MethodsWe used data from 21 case–control studies of ovarian cancer (19,066 controls, 11,972 invasive and 2,752 borderline cases). Study-specific odds ratios (OR) and 95xa0% confidence intervals (CI) were obtained from logistic regression models and combined into a pooled odds ratio using a random effects model.ResultsCurrent cigarette smoking increased the risk of invasive mucinous (ORxa0=xa01.31; 95xa0% CI: 1.03–1.65) and borderline mucinous ovarian tumors (ORxa0=xa01.83; 95xa0% CI: 1.39–2.41), while former smoking increased the risk of borderline serous ovarian tumors (ORxa0=xa01.30; 95xa0% CI: 1.12–1.50). For these histological types, consistent dose–response associations were observed. No convincing associations between smoking and risk of invasive serous and endometrioid ovarian cancer were observed, while our results provided some evidence of a decreased risk of invasive clear cell ovarian cancer.ConclusionsOur results revealed marked differences in the risk profiles of histological types of ovarian cancer with regard to cigarette smoking, although the magnitude of the observed associations was modest. Our findings, which may reflect different etiologies of the histological types, add to the fact that ovarian cancer is a heterogeneous disease.


Nicotine & Tobacco Research | 2007

Cotinine Levels in Relation to Smoking Behavior and Addiction in Young Adolescent Smokers

Mark L. Rubinstein; Pamela J. Thompson; Neal L. Benowitz; Saul Shiffman; Anna-Barbara Moscicki

The goal of this study was to identify associations among self-reported nicotine exposure, nicotine addiction, and actual nicotine intake as measured by salivary cotinine levels in adolescent smokers. A total of 170 adolescent smokers with a mean age of 15 years were recruited from seven northern Californian public high schools. Data were collected on smoking behaviors, addiction, craving, and withdrawal. Nicotine dependence was assessed using a modified teen Fagerström Tolerance Questionnaire (mtFTQ), a modified Nicotine Dependence Syndrome Scale (mNDSS), and a simple self-rating. Withdrawal was assessed using the Minnesota Withdrawal Questionnaire, and craving was assessed using a survey created by the authors. Salivary cotinine levels were collected from and analysed in participants who self-identified as smokers; data from the 54 participants who smoked in the past 4 days and whose salivary cotinine levels were greater than 0.1 ng/ml were used in the analysis. Among this group of adolescent smokers, the mean number of cigarettes smoked per day was 3.51 (SD = 3.44) and the mean level of salivary cotinine was 44.1 ng/ml (Mdn = 24.2). Even at this low level of nicotine exposure, cotinine was highly correlated with measures of nicotine dependence such as the mtFTQ (r = 0.497, p = .001), NDSS (r = 0.439, p = .002), timing of craving in the morning (r = -0.601, p = .000), and self-rated addiction (r = 0.562, p = .000). Most interesting, cotinine levels reached a plateau at around 4-5 cigarettes/day.


PLOS ONE | 2011

The Obesity-Associated Polymorphisms FTO rs9939609 and MC4R rs17782313 and Endometrial Cancer Risk in Non-Hispanic White Women

Galina Lurie; Mia M. Gaudet; Amanda B. Spurdle; Michael E. Carney; Lynne R. Wilkens; Hannah P. Yang; Noel S. Weiss; Penelope M. Webb; Pamela J. Thompson; Keith Y. Terada; Veronica Wendy Setiawan; Timothy R. Rebbeck; Jennifer Prescott; Irene Orlow; Tracy O'Mara; Sara H. Olson; Steven A. Narod; Rayna K. Matsuno; Jolanta Lissowska; Xiaolin Liang; Douglas A. Levine; Loic Le Marchand; Laurence N. Kolonel; Brian E. Henderson; Montserrat Garcia-Closas; Jennifer A. Doherty; Immaculata De Vivo; Chu Chen; Louise A. Brinton; Mohammad Akbari

Overweight and obesity are strongly associated with endometrial cancer. Several independent genome-wide association studies recently identified two common polymorphisms, FTO rs9939609 and MC4R rs17782313, that are linked to increased body weight and obesity. We examined the association of FTO rs9939609 and MC4R rs17782313 with endometrial cancer risk in a pooled analysis of nine case-control studies within the Epidemiology of Endometrial Cancer Consortium (E2C2). This analysis included 3601 non-Hispanic white women with histologically-confirmed endometrial carcinoma and 5275 frequency-matched controls. Unconditional logistic regression models were used to assess the relation of FTO rs9939609 and MC4R rs17782313 genotypes to the risk of endometrial cancer. Among control women, both the FTO rs9939609 A and MC4R rs17782313 C alleles were associated with a 16% increased risk of being overweight (pu200a=u200a0.001 and pu200a=u200a0.004, respectively). In case-control analyses, carriers of the FTO rs9939609 AA genotype were at increased risk of endometrial carcinoma compared to women with the TT genotype [odds ratio (OR) u200a=u200a1.17; 95% confidence interval (CI): 1.03–1.32, pu200a=u200a0.01]. However, this association was no longer apparent after adjusting for body mass index (BMI), suggesting mediation of the gene-disease effect through body weight. The MC4R rs17782313 polymorphism was not related to endometrial cancer risk (per allele ORu200a=u200a0.98; 95% CI: 0.91–1.06; pu200a=u200a0.68). FTO rs9939609 is a susceptibility marker for white non-Hispanic women at higher risk of endometrial cancer. Although FTO rs9939609 alone might have limited clinical or public health significance for identifying women at high risk for endometrial cancer beyond that of excess body weight, further investigation of obesity-related genetic markers might help to identify the pathways that influence endometrial carcinogenesis.

Collaboration


Dive into the Pamela J. Thompson's collaboration.

Top Co-Authors

Avatar

Marc T. Goodman

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Michael E. Carney

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roberta B. Ness

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Estrid Høgdall

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mary Anne Rossing

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Penelope M. Webb

QIMR Berghofer Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge